bromodeoxyuridine has been researched along with Behavior Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinoi, E; Ikeno, S; Kakuda, T; Kokubo, H; Nakamichi, N; Nakamura, S; Nakazato, R; Takarada, T; Yoneda, Y | 1 |
| Cash-Padgett, T; Ishii, K; Ishizuka, K; Jaaro-Peled, H; Kamiya, A; Kubo, KI; Nakajima, K; Niwa, M; Saito, A; Sawa, A; Sumitomo, A; Taniguchi, Y; Tomoda, T | 1 |
| Fujiwara, M; Kuwagata, M; Mishima, K; Morishima, A; Muneoka, K; Ogawa, T; Orito, K; Takata, J | 1 |
| Ashery-Padan, R; Davidoff, MS; Molnár, Z; Piñon, MC; Radyushkin, K; Stoykova, A; Tonchev, AB; Tuoc, TC | 1 |
| Cardon, M; Cohen, H; Lewitus, GM; Ron-Harel, N; Schwartz, M | 1 |
| De Gasperi, R; Elder, GA; Gama Sosa, MA | 1 |
| Ibi, D; Kamei, H; Koike, H; Kuwahara, Y; Mizoguchi, H; Nabeshima, T; Nagai, T; Takuma, K; Tsuritani, K; Yamada, K; Yoneda, Y | 1 |
| Aloe, L; Amendola, T; Antonelli, A; Fiore, M; Korf, J; Westenbroek, C | 1 |
1 review(s) available for bromodeoxyuridine and Behavior Disorders
| Article | Year |
|---|---|
Research update: neurogenesis in adult brain and neuropsychiatric disorders.
Topics: Adult; Alzheimer Disease; Animals; Antidepressive Agents; Bromodeoxyuridine; Cell Differentiation; Hippocampus; Humans; Immunohistochemistry; Mental Disorders; Neurodegenerative Diseases; Neurons; Olfactory Bulb; Stem Cell Transplantation | 2006 |
7 other study(ies) available for bromodeoxyuridine and Behavior Disorders
| Article | Year |
|---|---|
Daily oral intake of theanine prevents the decline of 5-bromo-2'-deoxyuridine incorporation in hippocampal dentate gyrus with concomitant alleviation of behavioral abnormalities in adult mice with severe traumatic stress.
Topics: Administration, Oral; Animals; Behavior, Animal; Bromodeoxyuridine; Dentate Gyrus; Disease Models, Animal; Glutamates; Locomotion; Male; Mental Disorders; Mice, Inbred Strains; Motor Activity; Severity of Illness Index; Stress Disorders, Post-Traumatic | 2015 |
DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Cell Proliferation; Cerebral Cortex; Embryo, Mammalian; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Humans; Mental Disorders; Mice; Mice, Transgenic; Nerve Tissue Proteins; RNA Interference; Transfection | 2016 |
Characteristic behavioral anomalies in rats prenatally exposed to 5-bromo-2'-deoxyuridine.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Antimetabolites; Anxiety Disorders; Behavior, Animal; Biogenic Monoamines; Brain; Bromodeoxyuridine; Central Nervous System Stimulants; Disease Models, Animal; Female; Male; Maze Learning; Mental Disorders; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2009 |
Selective cortical layering abnormalities and behavioral deficits in cortex-specific Pax6 knock-out mice.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Bromodeoxyuridine; Cell Adhesion Molecules, Neuronal; Cell Cycle; Cell Differentiation; Cell Movement; Cerebral Cortex; Conditioning, Classical; Congenital Abnormalities; DNA-Binding Proteins; Embryo, Mammalian; Extracellular Matrix Proteins; Eye Proteins; Fear; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Homeodomain Proteins; Indoles; Ki-67 Antigen; Memory Disorders; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Neurogenesis; Neurons; Pain Threshold; Paired Box Transcription Factors; PAX6 Transcription Factor; Psychomotor Performance; Reaction Time; Reelin Protein; Repressor Proteins; Serine Endopeptidases; Transcription Factors | 2009 |
Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders.
Topics: Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Hippocampus; Kisspeptins; Lymphocytes; Male; Mental Disorders; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Neural Inhibition; Neurogenesis; Peptides; Poly C; Poly G; Pregnancy; Prenatal Exposure Delayed Effects; Proteins; Psychoacoustics; Rats; Reaction Time; Reflex, Startle; Sensory Gating | 2010 |
Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Dentate Gyrus; DNA-Binding Proteins; Emotions; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation, Developmental; Hippocampus; Male; Memory Disorders; Mental Disorders; Mice; Mice, Inbred ICR; Neuronal Plasticity; Neurons; Nuclear Receptor Subfamily 4, Group A, Member 2; Selective Serotonin Reuptake Inhibitors; Social Behavior; Social Isolation; Stem Cells; Transcription Factors | 2008 |
Bromodeoxyuridine and methylazoxymethanol exposure during brain development affects behavior in rats: consideration for a role of nerve growth factor and brain derived neurotrophic factor.
Topics: Animals; Antimetabolites; Behavior, Animal; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Choline O-Acetyltransferase; Female; Male; Maze Learning; Mental Disorders; Methylazoxymethanol Acetate; Nerve Growth Factor; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptor, Nerve Growth Factor; Teratogens | 2001 |